logo
[breadcrumb_custom]

Tag: CHRS Shares

ZM Stock
News

CHRS Stock on the Rise: A Promising Investment

Coherus Biosciences Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $8.65 on 04/17/23, and the lowest price during the same period was recorded at $1.43 on 11/10/23. 52-week price history of CHRS Stock A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Coherus Biosciences Inc’s current trading price is -71.68% away from its 52-week high, while its distance from the 52-week low is 71.32%. The stock’s price range during this period has fluctuated between $1.43 and $8.65. Shares of the company,

Finance

Coherus Biosciences Inc (CHRS) Stock: A Year of Highs and Lows

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Coherus Biosciences Inc’s current trading price is -73.41% away from its 52-week high, while its distance from the 52-week low is 60.83%. The stock’s price range over this period has fluctuated between $1.43 and $8.65. The company, operating within the financial sector, had a trading volume of approximately 2.86 million for the day, which was noticeably lower than the average daily share volume of 6.14 million over the last 3 months. Coherus Biosciences Inc saw a rather

News

CHRS’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Year to date metric has recorded a loss of -33.63%.However, over the last six months, we can see a stronger performance of -55.62%. Over the last 30 days, the price of CHRS has leaped by -4.74%. And in the last five days, it has fallen by -3.07%. Coherus Biosciences Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $8.65 on 04/17/23,

AMZN
Finance

Coherus Biosciences Inc (CHRS) Stock: A Year of Market Fluctuations

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Coherus Biosciences Inc’s current trading price is -72.72% away from its 52-week high, while its distance from the 52-week low is 65.02%. The stock’s price range over this period has fluctuated between $1.43 and $8.65. The company, operating within the financial sector, had a trading volume of approximately 3.1 million for the day, which was noticeably lower than the average daily share volume of 6.12 million over the last 3 months. Coherus Biosciences Inc’s market performance has

THMO
Stock

The CHRS Stock Puzzle: Unraveling Coherus Biosciences Inc’s Fluctuating Performance

Coherus Biosciences Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $8.65 on 04/17/23 and a low of $1.43 for the same time frame on 11/10/23. 52-week price history of CHRS Stock A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Coherus Biosciences Inc’s current trading price is -68.15% away from its 52-week high, while its distance from the 52-week low is 92.64%. The stock’s price range during this period has spanned from $1.43 to $8.65. In the Healthcare sector, the Coherus Biosciences Inc’s

THMO
News

Coherus Biosciences Inc (CHRS) Stock: From Low to High in 52 Weeks

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Coherus Biosciences Inc’s current trading price is -73.70% away from its 52-week high, while its distance from the 52-week low is 59.08%. The stock’s price range for this time frame has been between $1.43 and $8.65. The trading volume of the company’s shares in the Healthcare reached around 2.08 million for the day, which was evidently lower than the average daily volume of 7.03 million over the last three months. In terms of market performance, Coherus Biosciences Inc had

AMZN
Stock

CHRS’s Stock Market Adventure: -34.23% YTD Growth Amidst Volatility

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The metric has seen a significant loss of -34.23% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -54.56%. Over the past 30 days, the price of CHRS has leaped by -32.41%. And in the last five days, it has fallen by -8.75%. Coherus Biosciences Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached

Stock

Coherus Biosciences Inc: Weathering Stock Market Storms with 305.13M Market Cap

Coherus Biosciences Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $9.39 on 01/24/23 and a low of $1.43 for the same time frame on 11/10/23. 52-week price history of CHRS Stock Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Coherus Biosciences Inc’s current trading price is -70.82% away from its 52-week high, while its distance from the 52-week low is 91.59%. The stock’s price range during the 52-week period has remained between $1.43 and $9.39. In